Plasma protein biomarkers linked to urological cancer risk reveal causal targets and potential therapies through Mendelian ...
The comparison of publications/citations in Mendelian randomisation from 2015 to 2024. On the top, it reflects the trend of total publications and citations each year. The keywords in this field are ...
Phase 3 Mascot study reaches key milestone for potential first-in-class therapy Lundbeck has announced that the final patient has been randomised ahead of schedule in its global phase 3 Mascot trial, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results